MediMabBio
- Biotech or pharma, therapeutic R&D
Immuno-oncology partnering opportunity: IL-15 immunocytokine based on differentiated anti-TIGIT antibody (licensing); anti-GITR agonistic antibody (R&D collaboration, joint development)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}